About NanoPass Technologies
NanoPass Technologies is a company based in Ness Ziona (Israel) founded in 2000. NanoPass Technologies has raised $12.5 million across 4 funding rounds from investors including West Pharmaceutical Services, Israel HealthCare Ventures and WFD Ventures. NanoPass Technologies offers products and services including MicronJet™. NanoPass Technologies operates in a competitive market with competitors including Valeritas, scPharmaceuticals, Crossject, CeQur and Vaxxas, among others.
- Headquarter Ness Ziona, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nanopass Technologies Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$12.5 M (USD)
in 4 rounds
-
Latest Funding Round
$6 M (USD), Series C
Jul 15, 2024
-
Investors
West Pharmaceutical Services
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of NanoPass Technologies
NanoPass Technologies offers a comprehensive portfolio of products and services, including MicronJet™.
Enables pain-free delivery of therapeutics and aesthetics using MEMS technology.
Funding Insights of NanoPass Technologies
NanoPass Technologies has successfully raised a total of $12.5M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $6 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in NanoPass Technologies
NanoPass Technologies has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include West Pharmaceutical Services, Israel HealthCare Ventures and WFD Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Investments in Israeli high-tech startups are managed by XT Hi-Tech.
|
Locked | Locked | Locked |
Investor details for NanoPass Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NanoPass Technologies
Investment portfolio details for NanoPass Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - NanoPass Technologies
Detailed financials for NanoPass Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nanopass Technologies Comparisons
Peer comparison for NanoPass Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of NanoPass Technologies
NanoPass Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Valeritas, scPharmaceuticals, Crossject, CeQur and Vaxxas, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable insulin patch pumps are developed for transdermal delivery.
|
|
| Locked | Locked | Locked |
Provider of a device for subcutaneous drug delivery for the treatment of bacterial infections and heart failure
|
|
| Locked | Locked | Locked |
Needle-free self-injectable drugs
|
|
| Locked | Locked | Locked |
Wearable insulin delivery patches are developed for mealtime dosing.
|
|
| Locked | Locked | Locked |
Developer of vaccines to treat cancer and infectious diseases
|
|
| Locked | Locked | Locked |
Drug-delivery platforms for pediatric wart treatments are developed.
|
Detailed competitors of NanoPass Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nanopass Technologies
Complete news archive for NanoPass Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NanoPass Technologies
NanoPass Technologies was founded in 2000 and raised its 1st funding round 7 years after it was founded.
NanoPass Technologies is headquartered in Ness Ziona, Israel. It is registered at Ness Ziona, Central District, Israel.
Daniel Levitats is the current CEO of NanoPass Technologies.
NanoPass Technologies is a funded company, having raised a total of $12.5M across 4 funding rounds to date.
NanoPass Technologies develops intradermal delivery solutions for vaccines and immunotherapies. They have developed, MicronJet needle, a single use microneedles-based device for intradermal delivery. It can be used with any standard syringe to painlessly deliver any liquid substance directly into the skin. The MicronJet can be used with any standard syringe to inject drugs, proteins and vaccines approved for that delivery route.
NanoPass Technologies's top competitors include scPharmaceuticals, Crossject and Vaxxas.
NanoPass Technologies offers MicronJet™.
NanoPass Technologies has 6 investors. Key investors include West Pharmaceutical Services, Israel HealthCare Ventures, WFD Ventures, D Capital Partners, and XT Hi-Tech.